"Carbapenems" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of beta-lactam antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom. THIENAMYCINS are a subgroup of carbapenems which have a sulfur atom as the first constituent of the side chain.
| Descriptor ID |
D015780
|
| MeSH Number(s) |
D02.065.589.099.124 D03.633.100.300.124
|
| Concept/Terms |
Carbapenems- Carbapenems
- Antibiotics, Carbapenem
- Carbapenem Antibiotics
|
Below are MeSH descriptors whose meaning is more general than "Carbapenems".
Below are MeSH descriptors whose meaning is more specific than "Carbapenems".
This graph shows the total number of publications written about "Carbapenems" by people in this website by year, and whether "Carbapenems" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 1 | 1 | 2 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 1 | 2 |
| 2015 | 2 | 1 | 3 |
| 2016 | 1 | 2 | 3 |
| 2017 | 0 | 3 | 3 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 3 | 3 |
| 2021 | 2 | 1 | 3 |
| 2022 | 1 | 3 | 4 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 2 | 3 |
| 2025 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carbapenems" by people in Profiles.
-
Multidrug-resistant gram-negative organisms: A primer on mechanisms of resistance and emerging therapies for the non-infectious diseases clinician. Am J Med Sci. 2026 Feb; 371(2):140-150.
-
Molecular characterization of blaNDM and other carbapenemases genes among carbapenem-resistant Enterobacterales from community-and hospital- acquired urinary tract infections. BMC Infect Dis. 2025 Oct 09; 25(1):1260.
-
Pharmacodynamic insights to support pneumonia treatment in a patient co-infected with two carbapenem-resistant bacteria. Int J Antimicrob Agents. 2025 Dec; 66(6):107633.
-
Carbapenem Resistant Serratia marcescens Harboring blaOXA-48, armA and aac(6')-Ib-cr Genes: The First Baseline Study from Pakistan. Curr Microbiol. 2025 Jun 03; 82(7):321.
-
Bacteriophage treatment is effective against carbapenem-resistant Klebsiella pneumoniae (KPC) in a neutropenic murine model of gastrointestinal translocation and renal infection. Antimicrob Agents Chemother. 2025 02 13; 69(2):e0091924.
-
Pharmacokinetics of cefiderocol in a patient with carbapenem-resistant Acinetobacter baumannii ventriculitis: A?case report. Pharmacotherapy. 2025 Jan; 45(1):66-69.
-
In vitro evaluation of using ceftazidime/avibactam against carbapenem-resistant Acinetobacter baumannii. J Glob Antimicrob Resist. 2024 09; 38:252-255.
-
Unveiling the structural features that regulate carbapenem deacylation in KPC-2 through QM/MM and interpretable machine learning. Phys Chem Chem Phys. 2023 Jan 04; 25(2):1349-1362.
-
Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease. Cell. 2022 09 29; 185(20):3705-3719.e14.
-
Systematic Analysis of Mobile Genetic Elements Mediating ?-Lactamase Gene Amplification in Noncarbapenemase-Producing Carbapenem-Resistant Enterobacterales Bloodstream Infections. mSystems. 2022 10 26; 7(5):e0047622.